i3 Health

02/22/2026

February is Cancer Prevention Awareness Month, dedicated to raising awareness about life-saving screenings and proactive care. By understanding individual risk factors and supporting legislative efforts to expand access to new screening technologies, we can improve outcomes and save lives.

02/21/2026

80% of cancer patients in the U.S. receive care in their local communities, but many miss out on life-saving precision medicine. Why? Because staying updated on molecular diagnostics is a full-time job in itself.

Oncology Data Advisor sat down with Kristin Ashcraft, CEO of OncoRx Insights, to discuss how AI is acting as a "clinical enabler""rather than a replacement: https://bit.ly/3O97vGL

02/20/2026

It started with tingling in his legs. Within a month, he couldn't climb stairs. Eric’s case looked like GBS at first, but his repeated relapses told a different story. Many patients face long diagnostic delays while their independence slips away.

Would you recognize the signs of acute-onset ?

Karissa Gable MD, Duke Health, breaks down the red flags and the latest treatment strategies to help patients like Eric in this , regain their quality of life: https://bit.ly/47NHLHm

02/20/2026

Faculty Friday Spotlight: Featuring Melinda Bachini

Chief Patient Officer of the Cholangiocarcinoma Foundation and a 14-year survivor of cholangiocarcinoma, Ms. Bachini brings her lived experience to national research committees and our Multidisciplinary Task Force on biliary tract cancer.

Learn more here: https://bit.ly/4nOZa7o

02/19/2026

Extrapulmonary can look like other , but they behave very differently. Dr. Andrew Hendifar and Dr. Danielle Hutchings (Cedars-Sinai) explain how diagnosis guides therapy:

Claim your CME/CPE credit here: https://bit.ly/46uq7HJView and download the slide deck here: https://www.slideshare.net/slideshow/clinical-challenges-in-extr...

02/19/2026

For today's , this throwback to an Oncology Data Advisor article explores the FDA’s updated approach to accelerated approvals and confirmatory trials.

In this article, Dr. Harpreet Singh (Precision for Medicine; former FDA Oncology Division Director) discusses how requiring confirmatory trials to be underway at the time of accelerated approval is changing oncology drug development.

Did you miss this article? Read it now: https://bit.ly/3OyNedD

02/18/2026

A young truck driver slips on ice and presents with lower back pain. An MRI reveals T3 compression fractures that have been present for 10 years, along with osteoporosis and osteopenia.

As his history unfolds, the clues start to mount:

- Baseline tryptase: 41 ng/mL
- 20+ years of an "unclear rash"
- Chronic GI symptoms
- Anaphylaxis after a Hymenoptera sting
- Brain fog

In Module 1: Diagnosing Systemic , Mariana Castells, MD, PhD (Brigham and Women's Hospital; Harvard Medical School) breaks down this complex case: https://bit.ly/3RmQbwe

02/18/2026

Your Update: Here’s what’s new!

Beyond the Skin: Uncovering Systemic Mastocytosis in Dermatology Practice: https://bit.ly/4tFL8sy

Prevention in Practice: Melanoma, Breast Cancer, and Beyond: https://bit.ly/4c2zpOv

Working With Cancer: Insights for Employer Support: https://bit.ly/3MD3hXh

02/17/2026

One Time Gene Therapy: The Future of Medicine in Hemophilia! Complete the full activity here: https://bit.ly/3Ini6vj

02/17/2026

Kelsey Marciano, PharmD, BCOP (UCHealth), covers treatment regimens, toxicity monitoring for BTK/BCL2 inhibitors, and roles in patient education.

Listen and claim 0.75 CPE ↓

Complete the activity and claim your credit today: https://bit.ly/4mN2WgR0:00 – Introduction2:49 - Epidemiology and burden4:24 – Indications for treatment in...

02/17/2026

How can we optimize long-term outcomes in a progressive disease like ?

Join Dr. Benjamin Cohen (Cleveland Clinic) in our interactive Virtual to follow a 32-year-old patient’s journey and explore how to navigate the rapidly evolving landscape of advanced biologic and nonbiologic therapies.

Start the challenge: https://bit.ly/4nrDvSC

02/16/2026

Today is the FINAL day to complete our 4 module Update with Christoph U. Correll, MD. From the history of dopamine blockers to the latest -approved muscarinic agonists, discover how the toolkit is being reinvented.

LAST CHANCE to claim 0.75 CME/NCPD/CPE: https://bit.ly/4i7uLyj